Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Drug Design and Discovery
Frontiers in Drug Design and Discovery is not currently indexed in Scopus. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1574-0889Verify ISSN ↗2212-1064Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Frontiers in Drug Design and Discovery indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2022 (also 2016–2018, 2009, 2006–2007)).
What is the impact factor of Frontiers in Drug Design and Discovery?
Frontiers in Drug Design and Discovery has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Frontiers in Drug Design and Discovery and what is its ISSN?
Frontiers in Drug Design and Discovery is published by Bentham Science Publishers. Its print ISSN is 1574-0889 and its online ISSN is 2212-1064.
Is Frontiers in Drug Design and Discovery in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Frontiers in Drug Design and Discovery open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Frontiers in Drug Design and Discovery for 7 years, between 2006 and 2022, with 10 years in that span missing. Coverage ended in 2022, 4 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 56 works and 115 citations for the title. Its papers appear as late as 2024, 2 years after Scopus coverage ended in 2022. That pattern fits a journal Scopus stopped indexing while it kept publishing, but it can also come from a changed ISSN or merged records. Confirm the journal's current status before submitting.
How well cited is Frontiers in Drug Design and Discovery? — open metrics via OpenAlex
Frontiers in Drug Design and Discovery has an h-index of 6 and a 2-year mean of 0 citations per paper (OpenAlex).
Frontiers in Drug Design and Discovery published 5 papers in 2024; its busiest recent year was 2005 with 17. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Frontiers in Drug Design and Discovery? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2022. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2022
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Bentham Science Publishers
Bentham Science Publishers has 239 other titles in our data; 119 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.